Tag:

Affiris

Latest Headlines

Latest Headlines

Affiris clears Phase I with Parkinson's vaccine candidate

August 1, 2014 | By
Austria-based vaccinemaker Affiris announced that its Parkinson's disease vaccine has met its primary endpoint in a small Phase I safety trial of patients receiving two different doses of the jab.

Michael J. Fox Foundation bankrolls AFFiRiS Parkinson's vaccine

October 13, 2011 | By
The Michael J. Fox Foundation (MJFF) will supply $1.5 million for an early clinical study of Affitope PD01, a vaccine being developed by Vienna, Austria-based AFFiRiS for the treatment of Parkinson's

AFFiRiS readies Alzheimer's vax for PhII study

April 28, 2010 | By
Austria's AFFiRiS AG is moving its lead Alzheimer's vaccine into a Phase II study that will test just how valuable the GlaxoSmithKline-partnered therapy is against a primary target in the fight
Related Tags
Press Releases
  • FDA Approves Strensiq™ (asfotase alfa) for Treatment of Patients with Perinatal-, Infantile- and Juvenile-Onset Hypophosphatasia (HPP)
  • Vet On Demand Launches First Tele-Health App for Pets, Available for iOS and Android Devices
  • Vet On Demand Launches First Tele-Health App for Pets, Available for iOS and Android Devices
  • Sequana Medical AG Raises CHF 9 million (USD 9.3M) in a Series C Extension
  • Oasmia Pharmaceutical AB Announces Pricing of Public Offering of American Depositary Shares and NASDAQ Listing
  • More Press Releases
Sponsored Links